INZY
Inozyme Pharma
INZY
INZY
Delisted
INZY was delisted on the 30th of June, 2025.
89 hedge funds and large institutions have $382M invested in Inozyme Pharma in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 33 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.52% less ownership
Funds ownership: 81.27% → 80.74% (-0.52%)
33% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 33
82% less call options, than puts
Call options by funds: $45K | Put options by funds: $246K
Holders
89
Holding in Top 10
2
Calls
$45K
Puts
$246K
Top Buyers
| 1 | +$5.8M | |
| 2 | +$4.5M | |
| 3 | +$2.09M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.87M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.15M |
Top Sellers
| 1 | -$3.52M | |
| 2 | -$2.34M | |
| 3 | -$1.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.6M |
| 5 |
Millennium Management
New York
|
-$1.59M |